New Industrial Collaboration with PexMachina Inc.

No alternative text description for this image

Advancing collaboration between academia and industry stands at the core of MR LATVIA's mission and its newest partnership underscores that commitment in action. MR LATVIA is proud to welcome PexMachina Inc. as its newest industrial collaborator, marking a significant step in bridging cutting-edge research infrastructure with industrial innovation. Representatives from PexMachina Inc., led by Matthias Kaiser, recently visited the MR LATVIA NMR facilities to lay the groundwork for joint research and a shared vision for the collaboration ahead.

Through the MR LATVIA NMR Access program, PexMachina Inc. will harness the facility's state-of-the-art NMR infrastructure to drive the development and validation of new quantum algorithms and computational pipelines for drug discovery, work with the potential to reshape how pharmaceutical research is conducted.

This collaboration stands as a powerful example of how advanced NMR infrastructure can accelerate scientific and industrial innovation, uniting deep academic expertise with the ambition of frontier industrial research. MR LATVIA looks forward to the impact this partnership will deliver for next-generation computational approaches in pharmaceutical research, and to the broader momentum it brings to the field. Special recognition goes to Andrew Lozoniuk, Research Services Coordination Specialist at NIRI, whose efforts were instrumental in making this collaboration possible.